Empowered Funds LLC Trims Holdings in Cardinal Health, Inc. $CAH

Empowered Funds LLC lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 78,652 shares of the company’s stock after selling 14,909 shares during the quarter. Empowered Funds LLC’s holdings in Cardinal Health were worth $13,173,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. WBI Investments LLC bought a new stake in shares of Cardinal Health during the 2nd quarter valued at $1,228,000. Westover Capital Advisors LLC raised its holdings in Cardinal Health by 75.8% during the second quarter. Westover Capital Advisors LLC now owns 4,262 shares of the company’s stock valued at $716,000 after acquiring an additional 1,837 shares during the period. Mount Lucas Management LP purchased a new position in shares of Cardinal Health in the second quarter valued at about $1,398,000. Dorsey & Whitney Trust CO LLC boosted its stake in shares of Cardinal Health by 3.6% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 3,102 shares of the company’s stock worth $521,000 after acquiring an additional 107 shares during the period. Finally, Raiffeisen Bank International AG grew its position in shares of Cardinal Health by 9.4% during the second quarter. Raiffeisen Bank International AG now owns 5,741 shares of the company’s stock worth $940,000 after purchasing an additional 494 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

CAH stock opened at $207.18 on Wednesday. The firm has a fifty day moving average price of $167.82 and a 200 day moving average price of $160.05. Cardinal Health, Inc. has a fifty-two week low of $114.60 and a fifty-two week high of $208.32. The firm has a market cap of $49.22 billion, a PE ratio of 32.12, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the prior year, the firm earned $1.88 earnings per share. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Analysts Set New Price Targets

A number of research firms recently commented on CAH. UBS Group boosted their price target on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Argus upped their target price on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Leerink Partners raised their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday. Finally, Evercore ISI boosted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Twelve research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $206.46.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.